Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Apr;33(4):878–884. doi: 10.1128/jcm.33.4.878-884.1995

Evaluation of risk and diagnostic value of quantitative assays for anti-Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG in immunodeficient patients.

J M Pinon 1, F Foudrinier 1, G Mougeot 1, C Marx 1, D Aubert 1, O Toupance 1, G Niel 1, M Danis 1, P Camerlynck 1, G Remy 1
PMCID: PMC228059  PMID: 7790453

Abstract

To determine their prognostic and diagnostic values for toxoplasmosis in immunodepressed subjects, we assayed immunoglobulin A (IgA) and IgE antibodies by means of immunocapture (IC) tests, with revelation done by using a suspension of T. gondii (ICT). We also carried out a simultaneous analytical study of IgG antibodies on cellulose acetate membranes by using the comparative immunological profile method and an enzyme-linked immunofiltration assay (ELIFA). A total of 1,238 samples (serum, cerebrospinal fluid, and aqueous humor from 318 patients) were tested. IgA and IgE antibodies were detected in all heart, kidney, and liver transplant recipients with clinical manifestations of toxoplasmosis; IgA was detected in the aqueous humor of a patient with chorioretinitis. In patients with AIDS-related toxoplasmosis, including the cerebral form, IgA and IgE antibodies or a significant modification of ELIFA IgG values were observed in 38, 19, and 25% of patients, respectively. IgM was detected by ICT only in 12% of patients and aided the diagnosis in 1 of 71 patients. IC tests for specific IgA and IgE alone and combined with ELIFA were positive in 39 and 46% of patients who developed clinical toxoplasmosis, respectively. In a serial study of 16 patients in whom at least one of these three tests was positive, a significant immunological signal sometimes preceded clinical onset by 1, 6, and even 17 months. Similarly, in a group of human immunodeficiency virus-infected patients with evidence of previous exposure to T. gondii but no clinical manifestations, IgA, IgE, and IgA and/or IgE antibodies were detected in only 11, 4, and 12% of patients, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Full Text

The Full Text of this article is available as a PDF (207.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Araujo F. G., Remington J. S. Toxoplasmosis in immunocompromised patients. Eur J Clin Microbiol. 1987 Feb;6(1):1–2. doi: 10.1007/BF02097180. [DOI] [PubMed] [Google Scholar]
  2. Bessières M. H., Roques C., Berrebi A., Barre V., Cazaux M., Séguéla J. P. IgA antibody response during acquired and congenital toxoplasmosis. J Clin Pathol. 1992 Jul;45(7):605–608. doi: 10.1136/jcp.45.7.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burg J. L., Grover C. M., Pouletty P., Boothroyd J. C. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol. 1989 Aug;27(8):1787–1792. doi: 10.1128/jcm.27.8.1787-1792.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Decoster A., Darcy F., Caron A., Capron A. IgA antibodies against P30 as markers of congenital and acute toxoplasmosis. Lancet. 1988 Nov 12;2(8620):1104–1107. doi: 10.1016/s0140-6736(88)90523-5. [DOI] [PubMed] [Google Scholar]
  5. Dupouy-Camet J., de Souza S. L., Maslo C., Paugam A., Saimot A. G., Benarous R., Tourte-Schaefer C., Derouin F. Detection of Toxoplasma gondii in venous blood from AIDS patients by polymerase chain reaction. J Clin Microbiol. 1993 Jul;31(7):1866–1869. doi: 10.1128/jcm.31.7.1866-1869.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Frenkel J. K., Escajadillo A. Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis. Am J Trop Med Hyg. 1987 May;36(3):517–522. doi: 10.4269/ajtmh.1987.36.517. [DOI] [PubMed] [Google Scholar]
  7. Hassl A., Aspöck H. Antigens of Toxoplasma gondii recognized by sera of AIDS patients before, during, and after clinically important infections. Zentralbl Bakteriol. 1990 Apr;272(4):514–525. doi: 10.1016/s0934-8840(11)80053-8. [DOI] [PubMed] [Google Scholar]
  8. Hofflin J. M., Remington J. S. Tissue culture isolation of Toxoplasma from blood of a patient with AIDS. Arch Intern Med. 1985 May;145(5):925–926. [PubMed] [Google Scholar]
  9. Holland G. N. Ocular toxoplasmosis in the immunocompromised host. Int Ophthalmol. 1989 Dec;13(6):399–402. doi: 10.1007/BF02306488. [DOI] [PubMed] [Google Scholar]
  10. Holliman R. E., Johnson J. D., Savva D. Diagnosis of cerebral toxoplasmosis in association with AIDS using the polymerase chain reaction. Scand J Infect Dis. 1990;22(2):243–244. doi: 10.3109/00365549009037911. [DOI] [PubMed] [Google Scholar]
  11. Holliman R. E. Toxoplasmosis and the acquired immune deficiency syndrome. J Infect. 1988 Mar;16(2):121–128. doi: 10.1016/s0163-4453(88)93847-9. [DOI] [PubMed] [Google Scholar]
  12. Huskinson J., Stepick-Biek P. N., Araujo F. G., Thulliez P., Suzuki Y., Remington J. S. Toxoplasma antigens recognized by immunoglobulin G subclasses during acute and chronic infection. J Clin Microbiol. 1989 Sep;27(9):2031–2038. doi: 10.1128/jcm.27.9.2031-2038.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Huskinson J., Thulliez P., Remington J. S. Toxoplasma antigens recognized by human immunoglobulin A antibodies. J Clin Microbiol. 1990 Dec;28(12):2632–2636. doi: 10.1128/jcm.28.12.2632-2636.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Israelski D. M., Tom C., Remington J. S. Zidovudine antagonizes the action of pyrimethamine in experimental infection with Toxoplasma gondii. Antimicrob Agents Chemother. 1989 Jan;33(1):30–34. doi: 10.1128/aac.33.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Köppen S., Grünewald T., Jautzke G., Gottschalk J., Pohle H. D., Ruf B. Prevention of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine. Clin Investig. 1992 Jun;70(6):508–512. doi: 10.1007/BF00210233. [DOI] [PubMed] [Google Scholar]
  16. Le Fichoux Y., Marty P., Chan H. Les IgA sériques spécifiques dans le diagnostic de la toxoplasmose. Ann Pediatr (Paris) 1987 May;34(5):375–379. [PubMed] [Google Scholar]
  17. Lindsay D. S., Blagburn B. L., Hall J. E., Tidwell R. R. Activity of pentamidine and pentamidine analogs against Toxoplasma gondii in cell cultures. Antimicrob Agents Chemother. 1991 Sep;35(9):1914–1916. doi: 10.1128/aac.35.9.1914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Luft B. J., Remington J. S. AIDS commentary. Toxoplasmic encephalitis. J Infect Dis. 1988 Jan;157(1):1–6. doi: 10.1093/infdis/157.1.1. [DOI] [PubMed] [Google Scholar]
  19. Marx-Chemla C., Thelliez E., Foudrinier F., Aubert D., Bonhomme A., Ducasse A., Pinon J. M. Toxoplasmose oculaire: mise en évidence de toxoplasmes libres dans l'humeur aqueuse. Presse Med. 1993 Apr 24;22(15):734–734. [PubMed] [Google Scholar]
  20. Mejia G., Leiderman E., Builes M., Henao J., Arbelaez M., Arango J. L., Borrero J. Transmission of toxoplasmosis by renal transplant. Am J Kidney Dis. 1983 May;2(6):615–617. doi: 10.1016/s0272-6386(83)80041-9. [DOI] [PubMed] [Google Scholar]
  21. Mirlesse V., Jacquemard F., Daffos F. Toxoplasmose au cours de la grossesse. Diagnostic et nouvelles possibilités thérapeutiques. Presse Med. 1993 Feb 20;22(6):258–262. [PubMed] [Google Scholar]
  22. Pinon J. M., Poirriez J., Leroux B., Dupouy D., Quereux C., Garin J. P. Diagnostic précoce et surveillance de la toxoplasmose congénitale. Méthode des profils immunologiques comparés. Presse Med. 1987 Mar 21;16(10):471–474. [PubMed] [Google Scholar]
  23. Pinon J. M., Thoannes H., Gruson N. An enzyme-linked immuno-filtration assay used to compare infant and maternal antibody profiles in toxoplasmosis. J Immunol Methods. 1985 Feb 28;77(1):15–23. doi: 10.1016/0022-1759(85)90179-6. [DOI] [PubMed] [Google Scholar]
  24. Pinon J. M., Thoannes H., Pouletty P. H., Poirriez J., Damiens J., Pelletier P. Detection of IgA specific for toxoplasmosis in serum and cerebrospinal fluid using a non-enzymatic IgA-capture assay. Diagn Immunol. 1986;4(5):223–227. [PubMed] [Google Scholar]
  25. Pinon J. M., Toubas D., Marx C., Mougeot G., Bonnin A., Bonhomme A., Villaume M., Foudrinier F., Lepan H. Detection of specific immunoglobulin E in patients with toxoplasmosis. J Clin Microbiol. 1990 Aug;28(8):1739–1743. doi: 10.1128/jcm.28.8.1739-1743.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Porter S. B., Sande M. A. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med. 1992 Dec 3;327(23):1643–1648. doi: 10.1056/NEJM199212033272306. [DOI] [PubMed] [Google Scholar]
  27. Potasman I., Resnick L., Luft B. J., Remington J. S. Intrathecal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1988 Jan;108(1):49–51. doi: 10.7326/0003-4819-108-1-49. [DOI] [PubMed] [Google Scholar]
  28. Renoult E., Biava M. F., Aimone-Gastin I., Aouragh F., Hestin D., Kures L., Kessler M. Evolution and significance of Toxoplasma gondii antibody titers in kidney transplant recipients. Transplant Proc. 1992 Dec;24(6):2754–2755. [PubMed] [Google Scholar]
  29. Salt A., Sutehall G., Sargaison M., Woodward C., Barnes N. D., Calne R. Y., Wreghitt T. G. Viral and toxoplasma gondii infections in children after liver transplantation. J Clin Pathol. 1990 Jan;43(1):63–67. doi: 10.1136/jcp.43.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Savva D., Morris J. C., Johnson J. D., Holliman R. E. Polymerase chain reaction for detection of Toxoplasma gondii. J Med Microbiol. 1990 May;32(1):25–31. doi: 10.1099/00222615-32-1-25. [DOI] [PubMed] [Google Scholar]
  31. Stepick-Biek P., Thulliez P., Araujo F. G., Remington J. S. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J Infect Dis. 1990 Jul;162(1):270–273. doi: 10.1093/infdis/162.1.270. [DOI] [PubMed] [Google Scholar]
  32. Strittmatter C., Lang W., Wiestler O. D., Kleihues P. The changing pattern of human immunodeficiency virus-associated cerebral toxoplasmosis: a study of 46 postmortem cases. Acta Neuropathol. 1992;83(5):475–481. doi: 10.1007/BF00310023. [DOI] [PubMed] [Google Scholar]
  33. Suzuki Y., Remington J. S. Importance of membrane-bound antigens of Toxoplasma gondii and their fixation for serodiagnosis of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome. J Clin Microbiol. 1990 Oct;28(10):2354–2356. doi: 10.1128/jcm.28.10.2354-2356.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tirard V., Niel G., Rosenheim M., Katlama C., Ciceron L., Ogunkolade W., Danis M., Gentilini M. Diagnosis of toxoplasmosis in patients with AIDS by isolation of the parasite from the blood. N Engl J Med. 1991 Feb 28;324(9):634–634. doi: 10.1056/nejm199102283240914. [DOI] [PubMed] [Google Scholar]
  35. Torres R. A., Barr M., Thorn M., Gregory G., Kiely S., Chanin E., Carlo C., Martin M., Thornton J. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. Am J Med. 1993 Dec;95(6):573–583. doi: 10.1016/0002-9343(93)90352-p. [DOI] [PubMed] [Google Scholar]
  36. Vendrell J. P., Reynes J., Huguet M. F., Ngou J., Michard C., Atoui N., Pratlong F., Segondy M., Serre A. In-vitro synthesis of antibodies to Toxoplasma gondii by lymphocytes from HIV-1-infected patients. Lancet. 1993 Jul 3;342(8862):22–23. doi: 10.1016/0140-6736(93)91883-n. [DOI] [PubMed] [Google Scholar]
  37. Weiblen B. J., Lee F. K., Cooper E. R., Landesman S. H., McIntosh K., Harris J. A., Nesheim S., Mendez H., Pelton S. I., Nahmias A. J. Early diagnosis of HIV infection in infants by detection of IgA HIV antibodies. Lancet. 1990 Apr 28;335(8696):988–990. doi: 10.1016/0140-6736(90)91061-e. [DOI] [PubMed] [Google Scholar]
  38. Wong S. Y., Hajdu M. P., Ramirez R., Thulliez P., McLeod R., Remington J. S. Role of specific immunoglobulin E in diagnosis of acute toxoplasma infection and toxoplasmosis. J Clin Microbiol. 1993 Nov;31(11):2952–2959. doi: 10.1128/jcm.31.11.2952-2959.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Zufferey J., Sugar A., Rudaz P., Bille J., Glauser M. P., Chave J. P. Prevalence of latent toxoplasmosis and serological diagnosis of active infection in HIV-positive patients. Eur J Clin Microbiol Infect Dis. 1993 Aug;12(8):591–595. doi: 10.1007/BF01973636. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES